Stockreport

All patients see benefit in Mass Brigham's cornea stem cell therapy trial [Yahoo! Finance]

MeiraGTx Holdings plc - Ordinary Shares  (MGTX) 
PDF Published in Nature Communications , results saw the study achieve success rates of 79% and 77% corneal repair with the cultivated autologous limbal epithelial cells (C [Read more]